Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is a healthcare REIT with a strong outlook due to their strategy of reducing leverage and increasing exposure to senior housing properties, which is expected to lead to accelerated earnings growth and a higher valuation. They have also performed well since going public and have a unique strategy of targeting smaller, higher-yielding properties in middle markets. While there are potential risks, such as market conditions and regulatory trends, NHP's strong board of directors and potential catalysts like the growing senior housing market provide confidence in their positive outlook.

Bears say

National Healthcare is heavily reliant on the SHOP segment for its revenue, which is currently facing occupancy challenges due to the pandemic and oversupply in the senior housing market. Changes in regulations and reimbursements could further impact their tenants' ability to pay rent. Additionally, the company's high concentration in the SHOP segment and ongoing capital recycling efforts pose risks if performance expectations are not met. The recent board and executive leadership changes may bring potential for growth but also bring uncertainty. Their high leverage and reliance on future growth for valuation make the company vulnerable to any unforeseen challenges.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Jun 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.